RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Seragy

Seragy

seragy develops biomarker-based tools for characterizing neurodegenerative diseases and supporting precision medicine.

Latest funding

$13.43M ·

Led by Commerzbank · Source: seragy.com

Funding history ↓
Website: seragy.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Diagnostics, Life Science, Medical, Neuroscience.
Based in: Hanover, Germany.
Last round: Oct 14, 2026 · 9 days ago.
Domain age: 6 months.
On Recent Funding since: Oct 16, 2026.
About Seragy

Seragy is a company based in Hanover, Germany. Recent Funding lists it under Health and bio. It raised $13.43M in a funding round in October 2026, led by Commerzbank, according to seragy.com. Investors on record include Land Niedersachsen, Michael J. Fox Foundation and Mittelständische Beteiligungsgesellschaft Niedersachsen (MBG). It was founded by Christiane Ritter and Thorsten Lührs.

Funding rounds

  1. Round · $13.43M
    Source: seragy.com
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Seragy: questions and answers

How much has Seragy raised?
Seragy has raised $13.43M in one sourced round on record, announced October 14, 2026.
Who invested in Seragy?
Investors on record for Seragy: Commerzbank, Land Niedersachsen, Michael J. Fox Foundation and Mittelständische Beteiligungsgesellschaft Niedersachsen (MBG). Commerzbank led its latest sourced round.
Who founded Seragy?
Seragy was founded by Christiane Ritter (Managing Partner | Science & Translation, Co-Founder) and Thorsten Lührs (Managing Partner | Strategy & Innovation, Co-Founder).
Where is Seragy based?
Seragy is based in Hanover, Germany.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/seragy (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy